À. Munck

12.7k total citations · 6 hit papers
141 papers, 7.0k citations indexed

About

À. Munck is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Nutrition and Dietetics. According to data from OpenAlex, À. Munck has authored 141 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Pulmonary and Respiratory Medicine, 24 papers in Surgery and 17 papers in Nutrition and Dietetics. Recurrent topics in À. Munck's work include Cystic Fibrosis Research Advances (100 papers), Neonatal Respiratory Health Research (47 papers) and Tracheal and airway disorders (37 papers). À. Munck is often cited by papers focused on Cystic Fibrosis Research Advances (100 papers), Neonatal Respiratory Health Research (47 papers) and Tracheal and airway disorders (37 papers). À. Munck collaborates with scholars based in France, United Kingdom and United States. À. Munck's co-authors include Félix Ratjen, Edward F. McKone, Jane C. Davies, K. De Boeck, J.S. Elborn, Claire Wainwright, Kevin W Southern, Isabelle Sermet‐Gaudelus, Carla Colombo and Patrick A. Flume and has published in prestigious journals such as Science, New England Journal of Medicine and Gastroenterology.

In The Last Decade

À. Munck

135 papers receiving 6.9k citations

Hit Papers

Lumacaftor–Ivacaftor in P... 1992 2026 2003 2014 2015 1992 2017 2014 2013 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
    2015 1.2k citations Claire Wainwright, Marco Cipolli et al. profile →
  2. Absence of Microsomal Triglyceride Transfer Protein in Individuals with Abetalipoproteinemia
    1992 585 citations À. Munck et al. profile →
  3. Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
    2017 553 citations À. Munck, Alexander Mœller et al. profile →
  4. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines
    2014 371 citations N. Kashirskaya, À. Munck et al. Journal of Cystic Fibrosis profile →
  5. Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation
    2013 369 citations Jane C. Davies, Claire Wainwright et al. American Journal of Respiratory and Critical Care Medicine profile →
  6. Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation
    2014 277 citations K. De Boeck, À. Munck et al. Journal of Cystic Fibrosis profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
À. Munck 5.4k 999 856 808 441 141 7.0k
Carla Colombo 4.2k 0.8× 1.7k 1.7× 660 0.8× 1.1k 1.4× 586 1.3× 219 6.6k
Valeria Raia 2.6k 0.5× 801 0.8× 1.2k 1.3× 985 1.2× 241 0.5× 148 5.3k
Drucy Borowitz 6.1k 1.1× 976 1.0× 640 0.7× 767 0.9× 1.3k 2.9× 115 7.3k
Joanne M. Bowen 5.7k 1.1× 714 0.7× 2.2k 2.5× 456 0.6× 124 0.3× 171 9.0k
Edward F. McKone 4.4k 0.8× 290 0.3× 608 0.7× 291 0.4× 233 0.5× 44 5.0k
Roslyn B. Mannon 933 0.2× 2.5k 2.5× 838 1.0× 965 1.2× 401 0.9× 205 7.6k
David Iklé 893 0.2× 852 0.9× 431 0.5× 444 0.5× 139 0.3× 96 4.0k
Naoki Inui 3.9k 0.7× 617 0.6× 953 1.1× 1.5k 1.9× 138 0.3× 331 6.9k
Michael R. Narkewicz 1.1k 0.2× 1.7k 1.7× 374 0.4× 1.7k 2.1× 114 0.3× 129 4.6k
Matthew D. Neal 1.2k 0.2× 1.5k 1.5× 979 1.1× 1.1k 1.3× 71 0.2× 213 7.0k

Countries citing papers authored by À. Munck

Since Specialization
Citations

This map shows the geographic impact of À. Munck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by À. Munck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites À. Munck more than expected).

Fields of papers citing papers by À. Munck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by À. Munck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by À. Munck. The network helps show where À. Munck may publish in the future.

Co-authorship network of co-authors of À. Munck

This figure shows the co-authorship network connecting the top 25 collaborators of À. Munck. A scholar is included among the top collaborators of À. Munck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with À. Munck. À. Munck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Munck, À., Kevin W Southern, J. Patrick Murphy, et al.. (2023). Cystic Fibrosis Cases Missed by Newborn Bloodspot Screening—Towards a Consistent Definition and Data Acquisition. International Journal of Neonatal Screening. 9(4). 65–65. 2 indexed citations
2.
Wilschanski, Michael, À. Munck, Marco Cipolli, et al.. (2023). ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis. Clinical Nutrition. 43(2). 413–445. 32 indexed citations
3.
Munck, À., et al.. (2020). Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening. Pediatric Pulmonology. 55(4). 918–928. 42 indexed citations
4.
Munck, À.. (2020). Inconclusive Diagnosis after Newborn Screening for Cystic Fibrosis. International Journal of Neonatal Screening. 6(1). 19–19. 23 indexed citations
5.
Munck, À., Eitan Kerem, Helmut Ellemunter, et al.. (2020). Tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for minimal function CFTR mutations. Journal of Cystic Fibrosis. 19(6). 962–968. 24 indexed citations
6.
Audrézet, M.‐P., Caroline Raynal, Isabelle Sermet‐Gaudelus, et al.. (2020). Penetrance is a critical parameter for assessing the disease liability of CFTR variants. Journal of Cystic Fibrosis. 19(6). 949–954. 11 indexed citations
7.
Burgel, Pierre‐Régis, À. Munck, I. Durieu, et al.. (2019). Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 201(2). 188–197. 92 indexed citations
8.
Southern, Kevin W, J Barben, Silvia Gärtner, et al.. (2019). Inconclusive diagnosis after a positive newborn bloodspot screening result for cystic fibrosis; clarification of the harmonised international definition. Journal of Cystic Fibrosis. 18(6). 778–780. 39 indexed citations
9.
Hubert, D., Isabelle Fajac, À. Munck, et al.. (2018). PND80 - AN OBSERVATIONAL STUDY OF IVACAFTOR IN PATIENTS WITH CYSTIC FIBROSIS IN FRANCE: FIRST INTERIM ANALYSIS OF HEALTH CARE RESOURCE UTILIZATION FROM THE BRIO STUDY. Value in Health. 21. S342–S342. 2 indexed citations
10.
Ratjen, Félix, Alexander Mœller, Robert Maykut, et al.. (2018). Eradication of early P. aeruginosa infection in children <7 years of age with cystic fibrosis: The early study. Journal of Cystic Fibrosis. 18(1). 78–85. 28 indexed citations
11.
Barben, Jürg, Carlo Castellani, J.E. Dankert-Roelse, et al.. (2016). The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe. Journal of Cystic Fibrosis. 16(2). 207–213. 85 indexed citations
12.
Burgel, Pierre‐Régis, Cécile Hamard, Nicolas Carlier, et al.. (2014). 292 Specific causes of mortality in CF patients in France 2007-2010. Journal of Cystic Fibrosis. 13. S123–S123. 1 indexed citations
13.
Roux, Anne‐Laure, Émilie Catherinot, Nathalie Soismier, et al.. (2014). Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. Journal of Cystic Fibrosis. 14(1). 63–69. 69 indexed citations
14.
Boeck, K. De, À. Munck, Seth Walker, et al.. (2014). Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation. Journal of Cystic Fibrosis. 13(6). 674–680. 277 indexed citations breakdown →
15.
Lakeman, Phillis, Gilles Thomas, J.E. Dankert-Roelse, et al.. (2008). CFTR Mutations in Turkish and North African Cystic Fibrosis Patients in Europe: Implications for Screening. Genetic Testing. 12(1). 25–35. 13 indexed citations
16.
Munck, À., Thierry Lamireau, B. Le Luyer, et al.. (2008). Pancreatic enzyme replacement therapy for young cystic fibrosis patients. Journal of Cystic Fibrosis. 8(1). 14–18. 31 indexed citations
17.
Mayell, Sarah, À. Munck, J.V. Craig, et al.. (2008). A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. Journal of Cystic Fibrosis. 8(1). 71–78. 95 indexed citations
18.
Dray, Xavier, D. Hubert, À. Munck, et al.. (2006). [Malnutrition and low bone mineralisation in adults with cystic fibrosis].. PubMed. 30(11). 1257–64. 1 indexed citations
19.
Southern, Kevin W, À. Munck, R. J. Pollitt, et al.. (2006). A survey of newborn screening for cystic fibrosis in Europe. Journal of Cystic Fibrosis. 6(1). 57–65. 178 indexed citations
20.
Munck, À.. (2005). Atteinte digestive de la mucoviscidose chez l’enfant. MTP. Médecine thérapeutique pédiatrie. 8(3). 197–203. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla Colombo Breakdown of academic impact, for papers by Valeria Raia Breakdown of academic impact, for papers by Drucy Borowitz Breakdown of academic impact, for papers by Joanne M. Bowen Breakdown of academic impact, for papers by Edward F. McKone Breakdown of academic impact, for papers by Roslyn B. Mannon Breakdown of academic impact, for papers by David Iklé Breakdown of academic impact, for papers by Naoki Inui Breakdown of academic impact, for papers by Michael R. Narkewicz Breakdown of academic impact, for papers by Matthew D. Neal
Rankless by CCL
2026